{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:22Z","timestamp":1787020222805,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Science and Technology, Govt. of West Bengal","award":["758(sanc.)\/ST\/P\/S&T\/9G-8\/2014, dated\u201427.11.2014"],"award-info":[{"award-number":["758(sanc.)\/ST\/P\/S&T\/9G-8\/2014, dated\u201427.11.2014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11565-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:59:04Z","timestamp":1759154344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of direct-acting antiviral treatment outcomes in patients with chronic hepatitis C infected with various HCV genotypes: Insights from a real-world cohort in West Bengal, India"],"prefix":"10.1186","volume":"25","author":[{"given":"Supradip","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyasi","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raina","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwesha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasana","family":"Baskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosanto Kumar","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-0530","authenticated-orcid":false,"given":"Provash Chandra","family":"Sadhukhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"11565_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2018.00396","author":"G Shi","year":"2018","unstructured":"Shi G, Suzuki T. Molecular basis of encapsidation of hepatitis C virus genome. Front Microbiol. 2018. https:\/\/doi.org\/10.3389\/FMICB.2018.00396.","journal-title":"Front Microbiol"},{"key":"11565_CR2","unstructured":"Hepatitis C. accessed September 8, n.d. (2023). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"11565_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cgh.2019.04.035","volume":"18","author":"S Seo","year":"2020","unstructured":"Seo S, Silverberg MJ, Hurley LB, Ready J, Saxena V, Witt D, et al. Prevalence of spontaneous clearance of hepatitis c virus infection doubled from 1998 to 2017. Clin Gastroenterol Hepatol. 2020;18:511\u20133. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.035.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11565_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/J.JCEH.2016.09.005","volume":"6","author":"RK Dhiman","year":"2016","unstructured":"Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the hepatitis C disease burden in Punjab, India. J Clin Exp Hepatol. 2016;6:224\u201332. https:\/\/doi.org\/10.1016\/J.JCEH.2016.09.005.","journal-title":"J Clin Exp Hepatol"},{"key":"11565_CR5","unstructured":"Global Hepatitis. Report 2024 Action for Access in Low- and Middle-Income Countries. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240091672."},{"key":"11565_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/J.JCEH.2014.05.006","volume":"4","author":"P Puri","year":"2014","unstructured":"Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, et al. Consensus statement of HCV task force of the Indian National association for study of the liver (INASL). Part I: status report of HCV infection in India. J Clin Exp Hepatol. 2014;4:106. https:\/\/doi.org\/10.1016\/J.JCEH.2014.05.006.","journal-title":"J Clin Exp Hepatol"},{"key":"11565_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/jgh.14466","volume":"34","author":"A Goel","year":"2019","unstructured":"Goel A, Seguy N, Aggarwal R. Burden of hepatitis C virus infection in India: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2019;34:321\u20139. https:\/\/doi.org\/10.1111\/jgh.14466.","journal-title":"J Gastroenterol Hepatol"},{"key":"11565_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0255-0857.118875","volume":"31","author":"J Christdas","year":"2013","unstructured":"Christdas J, Sivakumar J, David J, Daniel HDJ, Raghuraman S, Abraham P. Genotypes of hepatitis C virus in the Indian sub-continent: a decade-long experience from a tertiary care hospital in South India. Indian J Med Microbiol. 2013;31:349\u201353. https:\/\/doi.org\/10.4103\/0255-0857.118875.","journal-title":"Indian J Med Microbiol"},{"key":"11565_CR9","first-page":"133","volume":"14","author":"V Thakur","year":"2003","unstructured":"Thakur V, Guptan RC, Geeret M, Das BC, Sarin SK. Low prevalence of hepatitis C virus genotype \u2013\u20091b in chronic liver disease patients in India. EJIFCC. 2003;14:133.","journal-title":"EJIFCC"},{"key":"11565_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/J.JCV.2004.07.003","volume":"32","author":"S Chaudhuri","year":"2005","unstructured":"Chaudhuri S, Das S, Chowdhury A, Santra A, Bhattacharya SK, Naik TN. Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India. J Clin Virol. 2005;32:38\u201346. https:\/\/doi.org\/10.1016\/J.JCV.2004.07.003.","journal-title":"J Clin Virol"},{"key":"11565_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4103\/IJMM.IJMM_17_371","volume":"36","author":"B Barman","year":"2018","unstructured":"Barman B, Bora K, Lynrah K, Lyngdoh W, Jamil M. Hepatitis C virus and its genotypes in chronic liver disease patients from Meghalaya, Northeast India. Indian J Med Microbiol. 2018;36:376\u201380. https:\/\/doi.org\/10.4103\/IJMM.IJMM_17_371.","journal-title":"Indian J Med Microbiol"},{"key":"11565_CR12","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3748\/WJG.V13.I17.2406","volume":"13","author":"J Dubuisson","year":"2007","unstructured":"Dubuisson J. Hepatitis C virus proteins. World J Gastroenterol. 2007;13:2406\u201315. https:\/\/doi.org\/10.3748\/WJG.V13.I17.2406.","journal-title":"World J Gastroenterol"},{"key":"11565_CR13","doi-asserted-by":"publisher","first-page":"20509","DOI":"10.1073\/PNAS.1105797108\/","volume":"108","author":"MH Powdrill","year":"2011","unstructured":"Powdrill MH, Tchesnokov EP, Kozak RA, Russell RS, Martin R, Svarovskaia ES, et al. Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance. Proc Natl Acad Sci U S A. 2011;108:20509\u201313. https:\/\/doi.org\/10.1073\/PNAS.1105797108\/\/DCSUPPLEMENTAL\/PNAS.1105797108_SI.PDF","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11565_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/OFID\/OFZ076","author":"C Hedskog","year":"2019","unstructured":"Hedskog C, Parhy B, Chang S, Zeuzem S, Moreno C, Shafran SD, et al. Identification of 19 novel hepatitis C virus subtypes-further expanding HCV classification. Open Forum Infect Dis. 2019. https:\/\/doi.org\/10.1093\/OFID\/OFZ076.","journal-title":"Open Forum Infect Dis"},{"key":"11565_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/S13337-020-00592-0","volume":"31","author":"M Keikha","year":"2020","unstructured":"Keikha M, Eslami M, Yousefi B, Ali-Hassanzadeh M, Kamali A, Yousefi M, et al. HCV genotypes and their determinative role in hepatitis C treatment. Virusdisease. 2020;31:235\u201340. https:\/\/doi.org\/10.1007\/S13337-020-00592-0.","journal-title":"Virusdisease"},{"key":"11565_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/00325481.2017.1311197","volume":"129","author":"R Juanbeltz","year":"2017","unstructured":"Juanbeltz R, Go\u00f1i Esarte S, \u00dariz-Otano JI, Mart\u00ednez Echeverr\u00eda A, Elizalde I, Zozaya JM, et al. Safety of oral direct acting antiviral regimens for chronic hepatitis C in real life conditions. Postgrad Med. 2017;129:476\u201383. https:\/\/doi.org\/10.1080\/00325481.2017.1311197.","journal-title":"Postgrad Med"},{"key":"11565_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1086\/523585","volume":"46","author":"F Poordad","year":"2008","unstructured":"Poordad F, Reddy KR, Martin P. Rapid virologic response: a new milestone in the management of chronic hepatitis C. Clin Infect Dis. 2008;46:78\u201384. https:\/\/doi.org\/10.1086\/523585.","journal-title":"Clin Infect Dis"},{"key":"11565_CR18","doi-asserted-by":"publisher","unstructured":"St. John TM, Medicine I. Chronic hepatitis. Third Ed. 2012;171\u2013e1864. https:\/\/doi.org\/10.1016\/B978-1-4377-1793-8.00019-4.","DOI":"10.1016\/B978-1-4377-1793-8.00019-4"},{"key":"11565_CR19","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/HEP.27950","volume":"62","author":"RT Chung","year":"2015","unstructured":"Chung RT, Davis GL, Jensen DM, Masur H, Saag MS, Thomas DL, et al. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62:932\u201354. https:\/\/doi.org\/10.1002\/HEP.27950.","journal-title":"Hepatology"},{"key":"11565_CR20","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/HEP.27726","volume":"61","author":"DR Nelson","year":"2015","unstructured":"Nelson DR, Cooper JN, Lalezari JP, Lawitz E, Pockros PJ, Gitlin N, et al. All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology. 2015;61:1127\u201335. https:\/\/doi.org\/10.1002\/HEP.27726.","journal-title":"Hepatology"},{"key":"11565_CR21","doi-asserted-by":"publisher","unstructured":"Das S, Sengupta A, Chatterjee M, Professor A. A brief study on the Sero-prevalence of hepatitis C infection in a tertiary care hospital in kolkata. IOSR journal of dental and medical sciences (IOSR-JDMS) e-ISSN n.d.;17:71\u20135. https:\/\/doi.org\/10.9790\/0853-1702137175","DOI":"10.9790\/0853-1702137175"},{"key":"11565_CR22","doi-asserted-by":"publisher","unstructured":"Yousaf A, Ghafoor A, Fatima N, Danish M. Gender-Specific frequency distribution of hepatitis C virus genotypes in Punjab province, pakistan: A clinically significant descriptive Cross-Sectional study. Cureus 2021;13. https:\/\/doi.org\/10.7759\/CUREUS.17480","DOI":"10.7759\/CUREUS.17480"},{"key":"11565_CR23","first-page":"115","volume":"4","author":"A Chakraborty","year":"2015","unstructured":"Chakraborty A, Biswas Pramanik S, Singha Roy D, Sarkar S, Chakraborty M, Nandi A. A Retrospective Study on the Sero-prevalence of Hepatitis C Infection in a Tertiary Care Hospital in Kolkata, India. IntJCurrMicrobiolAppSci. 2015;4:115\u201323.","journal-title":"IntJCurrMicrobiolAppSci"},{"key":"11565_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/J.1365-2893.2012.01621.X","volume":"20","author":"N Antaki","year":"2013","unstructured":"Antaki N, Bibert S, Kebbewar K, Asaad F, Baroudi O, Alideeb S, et al. IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4. J Viral Hepat. 2013;20:59\u201364. https:\/\/doi.org\/10.1111\/J.1365-2893.2012.01621.X.","journal-title":"J Viral Hepat"},{"key":"11565_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1128\/JCM.02407-15","volume":"54","author":"G Cloherty","year":"2016","unstructured":"Cloherty G, Talal A, Coller K, Steinhart C, Hackett J, Dawson G, et al. Role of serologic and molecular diagnostic assays in identification and management of hepatitis C virus infection. J Clin Microbiol. 2016;54:265\u201373. https:\/\/doi.org\/10.1128\/JCM.02407-15.","journal-title":"J Clin Microbiol"},{"key":"11565_CR26","doi-asserted-by":"publisher","first-page":"DC15","DOI":"10.7860\/JCDR\/2015\/12701.5977","volume":"9","author":"D Bhattacharjee","year":"2015","unstructured":"Bhattacharjee D, Mukherjee K, Chakroborti G, Ghosh R, Mandal N, Bose M. Correlation study between HCV genotypes distribution pattern and viral load in a tertiary care hospital in kolkata, India. J Clin Diagn Res. 2015;9:DC15. https:\/\/doi.org\/10.7860\/JCDR\/2015\/12701.5977.","journal-title":"J Clin Diagn Res"},{"key":"11565_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40265-016-0685-x","volume":"77","author":"A Chan","year":"2017","unstructured":"Chan A, Patel K, Naggie S. Genotype 3 infection: the last stand of hepatitis C virus. Drugs. 2017;77:131\u201344. https:\/\/doi.org\/10.1007\/s40265-016-0685-x.","journal-title":"Drugs"},{"key":"11565_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MCG.0000000000000872","volume":"53","author":"SC Gordon","year":"2019","unstructured":"Gordon SC, Trudeau S, Li J, Zhou Y, Rupp LB, Nerenz DR, et al.\u00a02019 Race, age, and geography impact hepatitis C genotype distribution in the united States. J Clin Gastroenterol. 53:40\u201350. https:\/\/doi.org\/10.1097\/MCG.0000000000000872.","journal-title":"J Clin Gastroenterol"},{"key":"11565_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/V17020269","volume":"17","author":"S Bakshi","year":"2025","unstructured":"Bakshi S, Chattopadhyay P, Ahammed M, Das R, Majumdar M, Dutta S, et al. Efficacy of different combinations of direct-acting antivirals against different hepatitis C virus-infected population groups: an experience in tertiary care hospitals in West bengal, India. Viruses. 2025;17: 269. https:\/\/doi.org\/10.3390\/V17020269.","journal-title":"Viruses"},{"key":"11565_CR30","unstructured":"Core Concepts - Treatment of HCV Genotype. 3 - Treatment of Chronic Hepatitis C Infection - Hepatitis C Online n.d. https:\/\/www.hepatitisc.uw.edu\/go\/treatment-infection\/treatment-genotype-3\/core-concept\/all (accessed May 25, 2023)."},{"key":"11565_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/CLD.1137","volume":"18","author":"DM Abhinav Anand","year":"2021","unstructured":"Abhinav Anand DM, Shalimar DM. Hepatitis C virus in india: challenges and successes. Clin Liver Dis (Hoboken). 2021;18:150. https:\/\/doi.org\/10.1002\/CLD.1137.","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"11565_CR32","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.2169\/INTERNALMEDICINE.53.3194","volume":"53","author":"N Mori","year":"2014","unstructured":"Mori N, Imamura M, Takaki S, Araki T, Hayes NC, Aisaka Y, et al. Hepatitis C virus (HCV) reactivation caused by steroid therapy for dermatomyositis. Intern Med. 2014;53:2689\u201393. https:\/\/doi.org\/10.2169\/INTERNALMEDICINE.53.3194.","journal-title":"Intern Med"},{"key":"11565_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1196\/ANNALS.1423.046","volume":"1110","author":"SD Henry","year":"2007","unstructured":"Henry SD, Metselaar HJ, Van Dijck J, Tilanus HW, Van Der Laan LJW. Impact of steroids on hepatitis C virus replication in vivo and in vitro. Ann N Y Acad Sci. 2007;1110:439\u201347. https:\/\/doi.org\/10.1196\/ANNALS.1423.046.","journal-title":"Ann N Y Acad Sci"},{"key":"11565_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/V16030371","volume":"16","author":"J Ferreira","year":"2024","unstructured":"Ferreira J, Bicho M, Serejo F. Effects of HCV clearance with direct-acting antivirals (DAAs) on liver stiffness, liver fibrosis stage and metabolic\/cellular parameters. Viruses. 2024;16: 371. https:\/\/doi.org\/10.3390\/V16030371.","journal-title":"Viruses"},{"key":"11565_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jhep.2020.11.021","volume":"74","author":"LAP Krassenburg","year":"2021","unstructured":"Krassenburg LAP, Maan R, Ramji A, Manns MP, Cornberg M, Wedemeyer H, et al. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity. J Hepatol. 2021;74:1053\u201363. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.021.","journal-title":"J Hepatol"},{"issue":"1","key":"11565_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-021-93881-7","volume":"11","author":"OA Saldarriaga","year":"2021","unstructured":"Saldarriaga OA, Dye B, Pham J, Wanninger TG, Millian D, Kueht M, et al. Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome. Sci Rep. 2021;11(1): 14506. https:\/\/doi.org\/10.1038\/S41598-021-93881-7.","journal-title":"Sci Rep"},{"key":"11565_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.14218\/JCTH.2018.00014","volume":"6","author":"T Huynh","year":"2018","unstructured":"Huynh T, Zhang J, Hu KQ. Hepatitis C. virus clearance by direct-acting antiviral results in rapid resolution of hepatocytic injury as indicated by both alanine aminotransferase and aspartate aminotransferase normalization. J Clin Transl Hepatol. 2018;6:258. https:\/\/doi.org\/10.14218\/JCTH.2018.00014.","journal-title":"J Clin Transl Hepatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11565-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11565-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11565-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:59:07Z","timestamp":1759154347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11565-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11565"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11565-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of the Indian Council of Medical Research- National Institute of Cholera and Enteric Diseases (currently known as Indian Council of Medical Research- National Institute for Research in Bacterial Infections), vide letter number- A-1\/2016-IEC. The study is in accordance with the Helsinki Declaration and International Conference on Harmonisation Good Clinical Practices guidelines, 2008. Patients were informed, and written consent was obtained from patients at the time of enrolment for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to the publication. All the authors listed have read the manuscript and are fully aware of this submission process. This manuscript has not been published and is not under consideration for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1180"}}